May 01, 2013
Authored and Edited by Adriana L. Burgy; Jeffrey A. Berkowitz
The Basics: IPR is short for inter partes review. IPR is a new trial proceeding conducted by the USPTO’s Patent Trial and Appeal Board (PTAB). A third party can file an IPR petition challenging the patentability of one or more claims in a patent for novelty (35 U.S.C. § 102) or obviousness (35 U.S.C. § 103) in view of patents and/or printed publications. The petition can be filed 9 months after the grant of the patent or issuance of a reissue patent or, if a post grant review is instituted, following termination of the post grant review.
Five Considerations BEFORE Filing: Here are five considerations before filing an IPR:
Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.